Based on the result, it is likely that a caspase-3 inhibitor is not an optimal solution for preventing neuronal death (and its consequences in the form of neurodegenerative diseases) because the inhibition of caspase-3 would also lead to a reduced ability of neurons to adapt. This evidence concerns the gene CASP3 and neurodegenerative disease.